Company Filing History:
1 out of 5,111 
1 out of 132 
1 out of 1,835 
Years Active: 2012
Title: Thomas Lecourt: Innovator in Pharmaceutical Compositions
Introduction
Thomas Lecourt is a notable inventor based in Noisy le Sec, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on α-galactoceramide analogs. His research focuses on the synthesis and application of these compounds, which hold promise in the treatment of cancer.
Latest Patents
Lecourt holds a patent for α-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them. This invention relates to the synthesis of α-galactoceramide analogs using unsaturated intermediate compounds, enabling their production through a metathesis reaction. The resulting analogs are valuable as active ingredients in pharmaceutical compositions, especially those with anti-cancer properties.
Career Highlights
Throughout his career, Thomas Lecourt has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Paris Descartes. His work has contributed to advancements in pharmaceutical research and development, particularly in the area of cancer treatment.
Collaborations
Lecourt has collaborated with notable colleagues, including Didier Dubreuil and Muriel Pipelier. These partnerships have further enriched his research and innovation in the pharmaceutical field.
Conclusion
Thomas Lecourt's contributions to the development of α-galactoceramide analogs highlight his role as an important figure in pharmaceutical innovation. His work continues to influence the landscape of cancer treatment and pharmaceutical compositions.